Big Surge in Invictus MD Strategies Corp (TSXV: GENE) (OTCQX: IVITF)

0

Invictus MD Strategies Corp has seen a huge surge in price and volume in recent days and Investors continues to bid it higher.

On February 25 IVITF announced its wholly-owned subsidiary, Acreage Pharms Ltd. has successfully completed testing on two batches of oil and is working to finalize its application to Health Canada to allow for the sale of bottled cannabis oil and cannabis resin.

Acreage Pharms’ closed-loop CO2 system performs Subcritical and Supercritical Fluid Extraction utilizing high-pressure carbon dioxide to extract essential oils from botanicals, using specific temperatures and pressures to withdraw different components from plants. The system is operating at full capacity to build inventory in anticipation of Acreage Pharms receiving Health Canada approval. The new product line is expected to include a 1-to-1 ratio of CBD to THC oil, high CBD oil, and high THC oil for both the medial and recreational markets.

Invictus MD Strategies Corp (TSXV: GENE) (OTCQX: IVITF) (FRA: 8IS1) is a global cannabis company offering a selection of products under a wide range of lifestyle brands. The Company’s integrated sales approach is defined by five pillars of distribution including medical, adult-use, international, Licensed Producer to Licensed Producer and retail stores. The Company boast includes KISS music legend and business mogul Gene Simmons as Chief Evangelist Officer.

Invictus operates two cannabis production facilities fully licensed under ACMPR in Canada and a third awaiting approval, featuring 100,000 square feet of available grow space today with 200,000 expected by January 2019 and 1 million by end of 2020. Invictus offers a diversified product portfolio with over 69 Health Canada approved strains that will be sold under four lifestyle-inspired cannabis brands for recreational users: Dukes, Zooey, Sterling & Hunt, and Sinister. Invictus employs a multifaceted distribution strategy including medical, recreational, international and retail.

Invictus product portfolio includes 69 Health Canada approved strains that will be sold under four lifestyle-inspired cannabis brands for recreational users: Dukes, Zooey, Sterling & Hunt, and Sinister. Each brand has been crafted for a specific target audience and his or her lifestyle.

To Find out the inside Scoop on Invictus Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

Recently Invictus entered into a binding letter of intent to create a joint venture with Cannamerica Brands Corp. and CBDistribution Company Ltd. with the intention of acquiring hemp biomass for extraction into CBD isolate using purpose-built facilities for large scale CBD extraction. This follows the December 2018 Farm bill which recharacterized hemp from a schedule 1 drug with high potential for abuse to the lowest-level listed drug (schedule 5) which includes small doses of medicines such as codeine. This allows for mass hemp production in the United States that is federally legal and the ability to move hemp across state lines. Hemp is defined in the United States as cannabis with less than 0.3% THC. CBD, a non-psychoactive cannabinoid found in cannabis, has had a surge in popularity over the past couple of years based on its a huge range of potential health benefits and uses.

Invictus intends to enter into a definitive joint venture agreement on or before January 31, 2019. Each of the parties will receive a one-third share of the joint venture in exchange for their respective contribution: Invictus will contribute a line of credit (“LOC”) in the amount of $5 million CAD which will be used to acquire extraction equipment, build out infrastructure and fund working capital. The LOC will be secured by a general security agreement over the joint venture and will bear interest at a rate of 5% per annum.

On the recent updates CEO George E. Kveton stated “We are expanding our portfolio to satisfy consumer demand, adding oils and concentrates to our line-up of premium flower products. Research shows oils are increasing in popularity and we need to remain nimble to keep abreast of market trends.”

Separately, Invictus has also granted 150,000 stock options to a certain advisor of the Company. Each stock option has an exercise price of $0.98 and is exercisable into one common share of the Company. The options vest immediately and are exercisable over a period of five years. The stock options were granted subject to the terms and conditions of the Company’s Stock Option Plan.

We have a Monster Pick Coming. Subscribe Right Now!

Currently trading at a $112 million market valuation Invictus is fully funded moving forward with $23 million in the treasury. The Company has virtually no debt and fast growing sales reporting $1,744,428 in revenues for the three months ended October 31, 2018 up from $600k for the same period last year. Invictus is on exciting cannabis play; the Company operates two cannabis production facilities fully licensed under ACMPR in Canada and a third awaiting approval, featuring 100,000 square feet of available grow space today with 200,000 expected by January 2019 and 1 million by end of 2020. We will be updating on Invictus when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with Invictus.

Sign Up now for our 100% FREE Penny Stock Newsletter

Disclosure: we hold no position in Invictus either long or short and we have not been compensated for this article.

Share.

Leave A Reply

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.